VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹104 Cr | ₹106 Cr | ₹77 Cr | ₹57 Cr | ₹38 Cr |
What is the latest Net Current Assets ratio of VIMTA LABS ?
| Year | Net Current Assets |
|---|---|
| Mar2024 | ₹104 Cr |
| Mar2023 | ₹106 Cr |
| Mar2022 | ₹77 Cr |
| Mar2021 | ₹57 Cr |
| Mar2020 | ₹38 Cr |
How is Net Current Assets of VIMTA LABS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2024 | ₹104 Cr | -2.68 | |
| Mar2023 | ₹106 Cr | 38.86 | |
| Mar2022 | ₹77 Cr | 35.29 | |
| Mar2021 | ₹57 Cr | 47.85 | |
| Mar2020 | ₹38 Cr | - | |
Compare Net Current Assets of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,963.1 Cr | -5.5% | -0.2% | -2.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -5.5% |
-0.2% |
-2.9% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses